This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Clinical & Regulatory Cannabinoid Research Conference

The programme will be based on a series of focussed, disease-based sessions that will include invited speakers, selected oral abstracts and panel discussions.

15–16 Apr 2021

Abstracts deadline: 29 Feb 2020

Registration deadline:

BMA Great Hall, London, UK - View map

  • Overview

The conference has been rescheduled for the 15th & 16th of April 2021.

More details will follow.

The aims of the conference are:

• Assemble leading preclinical scientists, clinical researchers, national regulators (MHRA andNICE), government bodies and cannabis-based medicinal products (CBMP) pharmaceuticalsuppliers together to align research strategies.

• Grow and stimulate CBMP pharmaceutical industry in the UK.

• Identify the implementation challenges for CBMPs clinical research.

• Educate healthcare professions.

Register here